The increasing threat of Pseudomonas aeruginosa high-risk clones

A Oliver, X Mulet, C López-Causapé, C Juan - Drug Resistance Updates, 2015 - Elsevier
The increasing prevalence of chronic and hospital-acquired infections produced by
multidrug-resistant (MDR) or extensively drug-resistant (XDR) Pseudomonas aeruginosa …

Epidemiology and Characteristics of Metallo-β-Lactamase-Producing Pseudomonas aeruginosa

DJ Hong, IK Bae, IH Jang, SH Jeong… - Infection & …, 2015 - synapse.koreamed.org
Metallo-β-lactamase-producing Pseudomonas aeruginosa (MPPA) is an important
nosocomial pathogen that shows resistance to all β-lactam antibiotics except monobactams …

ARGONAUT-I: activity of cefiderocol (S-649266), a siderophore cephalosporin, against Gram-negative bacteria, including carbapenem-resistant nonfermenters and …

MR Jacobs, AM Abdelhamed, CE Good… - Antimicrobial agents …, 2019 - Am Soc Microbiol
The activity of the siderophore cephalosporin cefiderocol is targeted against carbapenem-
resistant Gram-negative bacteria. In this study, the activity of cefiderocol against …

Intestinal carriage of carbapenemase-producing organisms: current status of surveillance methods

R Viau, KM Frank, MR Jacobs, B Wilson… - Clinical microbiology …, 2016 - Am Soc Microbiol
Carbapenemases have become a significant mechanism for broad-spectrum β-lactam
resistance in Enterobacteriaceae and other Gram-negative bacteria such as Pseudomonas …

Diversity and Distribution of Resistance Markers in Pseudomonas aeruginosa International High-Risk Clones

B Kocsis, D Gulyás, D Szabó - Microorganisms, 2021 - mdpi.com
Pseudomonas aeruginosa high-risk clones are disseminated worldwide and they are
common causative agents of hospital-acquired infections. In this review, we will summarize …

Therapies for multidrug resistant and extensively drug-resistant non-fermenting gram-negative bacteria causing nosocomial infections: a perilous journey toward ' …

NG El Chakhtoura, E Saade, A Iovleva… - Expert review of anti …, 2018 - Taylor & Francis
ABSTRACT Introduction: Non-fermenting Gram-negative bacilli are at the center of the
antimicrobial resistance epidemic. Acinetobacter baumannii and Pseudomonas aeruginosa …

Prevalence and risk factors associated with colonization and infection of extensively drug-resistant Pseudomonas aeruginosa: a systematic review

M Buhl, S Peter, M Willmann - Expert review of anti-infective …, 2015 - Taylor & Francis
Pseudomonas aeruginosa is a Gram-negative human pathogen with extensively drug-
resistant (XDR) strains emerging in hospitals across the globe. This systematic review is …

Transcending the challenge of evolving resistance mechanisms in Pseudomonas aeruginosa through β-lactam-enhancer-mechanism-based cefepime/zidebactam

AM Hujer, SH Marshall, AR Mack, KM Hujer… - MBio, 2023 - Am Soc Microbiol
Multi-drug resistant (MDR) Pseudomonas aeruginosa harbor a complex array of β-
lactamases and non-enzymatic resistance mechanisms. In this study, the activity of a β …

[HTML][HTML] Zooanthroponotic transmission of drug-resistant Pseudomonas aeruginosa, Brazil

MR Fernandes, FP Sellera, Q Moura… - Emerging Infectious …, 2018 - ncbi.nlm.nih.gov
We recovered VIM-2 carbapenemase-producing Pseudomonas aeruginosa isolates from an
infected dog, its owner, and the domestic environment. Genomic investigation revealed …

[HTML][HTML] Antibiotic resistance in Enterobacteriaceae from surface waters in urban Brazil highlights the risks of poor sanitation

PS Bartley, TN Domitrovic, VT Moretto… - The American journal …, 2019 - ncbi.nlm.nih.gov
Surface waters are an unappreciated reservoir of antimicrobial resistance (AMR). Poor
sanitation brings different species of environmental bacteria into contact, facilitating …